Board MeetingBoard Meeting
Amerise Biosciences approved Q1 FY27 results.
Amerise Biosciences Ltd531681 · Filed with the exchange
The company reported zero revenue from operations and a net loss of Rs 0.08 Cr for the quarter ended June 30, 2026, compared to a profit of Rs 0.06 Cr last year.
No comments yet. Be the first.